CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Armata Pharmaceuticals, Inc.

ARMP
$138MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for ARMP. That does not mean none is planned.

Get an email about ARMP's next catalysts

Track Armata Pharmaceuticals (ARMP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

1 upcoming event in our data (earnings).See the timeline

Catalyst Timeline

1 upcoming, 0 past

Earnings

ARMP Earnings Report

November 2026~

Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.57 | FQ end Sep/2026 | Call: tbd

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)πŸ‡ΊπŸ‡ΈNorth AmericaLOS ANGELES60 employees
Drug Pipeline

Frequently asked questions

What is in Armata Pharmaceuticals, Inc.'s drug pipeline?β†’

CatalystAlert tracks 7 drug candidates in Armata Pharmaceuticals, Inc.'s (ARMP) pipeline across Phase 2. Its lead program is AP-PA02 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Armata Pharmaceuticals, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Armata Pharmaceuticals, Inc. (ARMP) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track ARMP biotech catalysts?β†’

Add ARMP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Armata Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply